QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Toohey, M G Articles by Jones, K A Search for Related Content PubMed PubMed Citation Articles by Toohey, M G Articles by Jones, K A Social Bookmarking                   What's this?

Research Papers

In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions.

Molecular Biology and Virology Laboratory, Salk Institute, La Jolla, California 92037.

Abstract

Trans-activation of HIV-1 transcription by the viral regulatory protein Tat has been proposed recently to overcome a block to RNA polymerase II elongation in vivo imposed by 5'-untranslated leader sequences. Interestingly, however, only full-length transcripts, rather than prematurely terminated HIV RNAs, are synthesized in most cell-free transcription extracts. Here, we describe an in vitro system in which induction of a highly efficient RNA polymerase II termination or cotranscriptional RNA processing event creates short HIV RNAs with 3' ends that map to a region immediately downstream of the HIV-1 or HIV-2 promoters. Termination in vitro is sequence dependent, generating short HIV-1 RNAs of 58-61 nucleotides that resemble in vivo transcripts observed in the absence of Tat, and a distinct, longer transcript of approximately 125-130 nucleotides from the HIV-2 promoter. Deletion of promoter-proximal HIV-2 downstream sequences results in the loss of a discrete RNA but also fails to restore wild-type transcription, indicating that termination actually is specified at the promoter and occurs at a site positioned by one or more elements located immediately upstream of the 3' end of the short RNAs. Experiments with recombinant HIV-2 promoters and nucleoside analogs indicate that this event involves a concerted interaction between the promoter and orientation-dependent leader sequences and that RNA secondary structure formation may also be required. These data provide direct evidence for abbreviated HIV transcripts and an in vitro approach to understanding the roles of cellular and viral regulatory proteins that mediate this process at the HIV promoters.

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Z. Zhang, A. Klatt, A. J. Henderson, and D. S. Gilmour Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression Genes & Dev., July 1, 2007; 21(13): 1609 - 1614. [Abstract] [Full Text] [PDF]

				S. N. Richter, F. Belanger, P. Zheng, and T. M. Rana Dynamics of nascent mRNA folding and RNA-protein interactions: an alternative TAR RNA structure is involved in the control of HIV-1 mRNA transcription Nucleic Acids Res., September 10, 2006; 34(15): 4278 - 4292. [Abstract] [Full Text] [PDF]

				A. Michienzi, S. Li, J. A. Zaia, and J. J. Rossi A nucleolar TAR decoy inhibitor of HIV-1 replication PNAS, October 29, 2002; 99(22): 14047 - 14052. [Abstract] [Full Text] [PDF]

				J. W. Steinke, S. J. Kopytek, and D. O. Peterson Discrete promoter elements affect specific properties of RNA polymerase II transcription complexes Nucleic Acids Res., July 15, 2000; 28(14): 2726 - 2735. [Abstract] [Full Text] [PDF]

				D. H. Price P-TEFb, a Cyclin-Dependent Kinase Controlling Elongation by RNA Polymerase II Mol. Cell. Biol., April 15, 2000; 20(8): 2629 - 2634. [Full Text]

				G. Dallinger, H. Oberkofler, C. Seelos, and W. Patsch Transcriptional elongation of the rat apolipoprotein A-I gene: identification and mapping of two arrest sites and their signals J. Lipid Res., July 1, 1999; 40(7): 1229 - 1239. [Abstract] [Full Text]

				F. Pessler and N. Hernandez The HIV-1 Inducer of Short Transcripts Activates the Synthesis of 5,6-Dichloro-1-beta -D-benzimidazole-resistant Short Transcripts in Vitro J. Biol. Chem., February 27, 1998; 273(9): 5375 - 5384. [Abstract] [Full Text] [PDF]

				A Krumm, T Meulia, M Brunvand, and M Groudine The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes & Dev., November 1, 1992; 6(11): 2201 - 2213. [Abstract] [PDF]

				C T Sheline, L H Milocco, and K A Jones Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes & Dev., December 1, 1991; 5(12b): 2508 - 2520. [Abstract] [PDF]

				M F Laspia, A P Rice, and M B Mathews Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes & Dev., December 1, 1990; 4(12b): 2397 - 2408. [Abstract] [PDF]

				S Roy, U Delling, C H Chen, C A Rosen, and N Sonenberg A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes & Dev., August 1, 1990; 4(8): 1365 - 1373. [Abstract] [PDF]

				U Deuschle, R. Hipskind, and H Bujard RNA polymerase II transcription blocked by Escherichia coli lac repressor Science, April 27, 1990; 248(4954): 480 - 483. [Abstract] [PDF]

				R Kovelman and R G Roeder Sarkosyl defines three intermediate steps in transcription initiation by RNA polymerase III: application to stimulation of transcription by E1A. Genes & Dev., April 1, 1990; 4(4): 646 - 658. [Abstract] [PDF]

				A Stenlund and M R Botchan The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes & Dev., January 1, 1990; 4(1): 123 - 136. [Abstract] [PDF]